Erba Diagnostics (ERB) Return on Equity ROE from the second quarter 2015 to second quarter 2013 and annually, average high and low, overall ranking from Jun 30 2015 to Jun 30 2013 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Erba Diagnostics, Inc.  (ERB)

Erba Diagnostics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Erba Diagnostics in the second quarter 2015?
Erba Diagnostics, Inc. achieved a return on average equity (ROE) of 2.61 % in its second quarter 2015, this is above ERB's average return on equity of -1.91%.
Erba Diagnostics, Inc. shareholder's equity over the 12 months ending in its second quarter 2015 are valued at $17 million

ROE decreased relative to the period ending , due to the decline in net income.

Within the Laboratory Analytical Instruments industry 12 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2014 from to 2539.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2015)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter
Y / Y Equity Change 3.41 % 10.96 % 7.26 % 58.07 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 1 1 -1 -1
Return On Equity (TTM) 2.61 % 6.41 % 4.09 % -6.95 % -9.21 %
ERB's Total Ranking # 2539 # # # #
Equity (TTM) in Millions 16 18 18 17 16
Seq. Equity Change -7.21 % 1.42 % 5.37 % 4.29 % -0.44 %
Seq. Net Income Change - -76.75 % 446.56 % 47.97 % -

Back to ERB Management Effectiveness >> ERB's 5 Years Annual ROE >> Compare ERB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 13
Sector # 184
Overall # 2539

Return On Equity Statistics
High Average Low
6.41 %
-1.91 %
-13.43 %
(Mar 31 2014)   (Mar 31 2013)





ERB Annual Return On Equity (Dec 31 2013)
2013		 (Dec 31 2012)
2012


Total Equity in Millions 18 16 0 0 0
Y / Y Equity Change 7.26 % - - - -
Net Income in Millions 1 -2 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity 3.86 % -9.51 % - - -

Back to ERB Management Effectiveness >> ERB's 5 Years Annual ROE >> Compare ERB ROE to its Competitors




Annual Roe Comment
In 2013 ROE improved to 3.86 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ERB's' Return on Equity at Yahoo Finance
ERB's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ERB's Competitors
Subscribers only: Roe for Erba Diagnostics's Suppliers
Subscribers only: Return On Equity for ERB's Customers




Companies with similar Return On Equity at Jun 30 2015, within Healthcare Sector ROE
Nuvasive Inc  7.14 %
Tenet Healthcare Corp  6.78 %
Repligen Corp  6.67 %
Merit Medical Systems Inc  6.61 %
Hologic Inc  6.28 %
Agilent Technologies inc   6.23 %
Yunhong Green Cti Ltd   5.97 %
Synthorx, Inc.  5.94 %
Rti Surgical Holdings Inc   5.83 %
Integra Lifesciences Holdings Corp  5.79 %
Heska Corporation  5.30 %
Micron Solutions Inc  5.28 %
Omnova Solutions Inc  5.06 %
Magellan Health inc   4.96 %
Infusystem Holdings Inc  4.86 %
Conmed Corporation  4.66 %
Bio rad Laboratories Inc   4.34 %
Zimmer Biomet Holdings Inc   4.29 %
Adverum Biotechnologies Inc   3.68 %
Nature s Sunshine Products inc   3.61 %
Boston Scientific Corporation  3.47 %
Dyne Therapeutics Inc   2.92 %
Reliv International Inc  2.62 %
Erba Diagnostics, Inc.  2.61 %
Haemonetics Corporation  2.48 %
Progenics Pharmaceuticals Inc  2.36 %
Agile Therapeutics Inc  2.26 %
Cumberland Pharmaceuticals Inc   2.25 %
Intersect Ent Inc   1.99 %
Ardelyx inc   1.98 %

Date modified: 2026-09-08T15:21:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.